Literature DB >> 8891564

Changes in alveolar-arterial oxygen difference and oxygenation index during low-dose nitric oxide inhalation in 15 newborns with severe respiratory insufficiency.

Z Stranák1, V Zábrodský, J Simák.   

Abstract

UNLABELLED: We evaluated changes in alveolar-arterial oxygen differences (AaDO2) and oxygenation index (OI) during inhalation of low-dose nitric oxide (INO) in 15 newborns with severe respiratory insufficiency: congenital diaphragmatic hernia (CDH) -6, asphyxial lung disease -4, meconium aspiration syndrome (MAS) -2, respiratory distress syndrome -2, persistent pulmonary hypertension of newborn -1. Their mean birth weight was 2522 g (1030-3200 g, SD +/- 575), mean gestational age 36 weeks (29-39 weeks, SD +/- 3.2), mean initial AaDO2 = 607 mm Hg (574-628 mm Hg, SD +/- 14) and mean initial OI = 32 (6-57, SD +/- 12). INO was performed using the Pulmonox system (Messer Griesheim, Austria) at conventional regimens of mechanical ventilation. The initial value of 20 ppm nitric oxide (NO) was decreased 6 h later, first to 15 ppm and then, as quickly as possible, to 3 ppm. The mean inhalation period was 51 h (6-131 h, SD +/- 42). The initial value of AaDO2 and OI decreased significantly within the first 6 h of INO (P < 0.001). After the first 6 h, 4 patients died: 1 with MAS of an extrapulmonary cause and 3 CDH patients because of pulmonary hypoplasia. In the remaining 11 patients the decrease in AaDO2 and OI during the first 24 h of INO was highly significant (P < 0.0001).
CONCLUSION: In a heterogeneous group of 15 newborns with severe respiratory insufficiency, the initial AaDO2 and OI decreased significantly within the first 6 h of INO.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891564     DOI: 10.1007/bf02282844

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome.

Authors:  F J Walther; M J Benders; J O Leighton
Journal:  Pediatrics       Date:  1992-12       Impact factor: 7.124

2.  Criteria for extracorporeal membrane oxygenation in a population of infants with persistent pulmonary hypertension of the newborn.

Authors:  R Beck; K D Anderson; G D Pearson; J Cronin; M K Miller; B L Short
Journal:  J Pediatr Surg       Date:  1986-04       Impact factor: 2.545

Review 3.  The pharmacology of inhaled nitric oxide.

Authors:  A D Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

Review 4.  Treatment of newborn infants with inhaled nitric oxide.

Authors:  R H Mupanemunda; A D Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

5.  Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome.

Authors:  H Gerlach; R Rossaint; D Pappert; K J Falke
Journal:  Eur J Clin Invest       Date:  1993-08       Impact factor: 4.686

Review 6.  Inhaled nitric oxide in acute lung disease.

Authors:  W G Cioffi; H Ogura
Journal:  New Horiz       Date:  1995-02

Review 7.  Nitric oxide-related oxidants in acute lung injury.

Authors:  J A Royall; N W Kooy; J S Beckman
Journal:  New Horiz       Date:  1995-02

Review 8.  Inhaled nitric oxide in the adult respiratory distress syndrome and other lung diseases.

Authors:  W M Zapol; W E Hurford
Journal:  New Horiz       Date:  1993-11

9.  Extracorporeal membrane oxygenation in pediatric respiratory failure.

Authors:  R M Ortiz; R E Cilley; R H Bartlett
Journal:  Pediatr Clin North Am       Date:  1987-02       Impact factor: 3.278

10.  Guidelines for the safe administration of inhaled nitric oxide.

Authors:  O I Miller; D S Celermajer; J E Deanfield; D J Macrae
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.